In this context, it is interesting to note that xenogeneic GVHD also emerged as a major limiting factor in NSG mice bearing xenografts from established melanoma cell lines and receiving adoptive cell therapy with the melanoma-associated antigen MART-1-specific human T cells [28]. The gene discussed is MLANA; the disease is melanoma.